The Effectiveness of Acceptance and Commitment Therapy on Anxiety, Depression, and Lipid Profile of Patients with Type 2 Diabetes

Khosravani, Elahe; Sanagouye Moharer, Gholam Reza; Shirazi, Mahmood; Rezaei, Mrayam

doi:10.29252/mejds.0.0.147

Volume 12 - Articles-1401 MEJDS (2022) 12: 125 | Back to browse issues page

‎ 10.29252/mejds.0.0.147

‎ 20.1001.1.23222840.1399.0.0.156.5

Mendeley

Zotero

RefWorks

Khosravani E, Sanagouye Moharer G R, Shirazi M, Rezaei M. The Effectiveness of Acceptance and Commitment Therapy on Anxiety, Depression, and Lipid Profile of Patients with Type 2 Diabetes. MEJDS 2022; 12 :125-125
URL: http://jdisabilstud.org/article-1-1843-en.html

The Effectiveness of Acceptance and Commitment Therapy on Anxiety, Depression, and Lipid Profile of Patients with Type 2 Diabetes

Elahe Khosravani¹

, Gholam Reza Sanagouye Moharer ^*

¹, Mahmood Shirazi²

, Mrayam Rezaei³

1- Islamic Azad University, Zahedan Branch
2- University of Sistan and Baluchestan
3- Birjand University of Medical Sciences

Abstract: (2782 Views)

Background & Objective: Diabetes is one of the most common chronic metabolic diseases characterized by abnormalities in carbohydrate, protein, and fat metabolism. The most common symptoms are glucose intolerance or hyperglycemia, which causes short– and long–term complications of diabetes. Diabetes is a metabolic disorder characterized by insulin deficiency and secretion. Diabetes consists of two types, type 2 and type 1. In type 2 diabetes or non–insulin dependent diabetes, the produced insulin by the pancreas does not work well. Diabetes occurs when the pancreas does not release enough insulin or the secreted insulin does not work properly. Reports indicate an increase in the prevalence of type 2 diabetes in developing countries by 4%. The disease alone caused 4.9 million deaths worldwide in 2014, and it is estimated that by the year 2030, Iran will become one of the most populous countries in the world in terms of diabetes.
In the etiology of type 2 diabetes, the role of environmental factors is prominent. Studies have shown that complications are common in these patients, especially long–term complications such as cardiac, ophthalmic, and renal, as well as psychological problems in personal, family, and social relationships. Treating all these problems has a high cost, both directly and indirectly, for the patients and the government. Among the most important complications are psychological disorders (anxiety and depression) that negatively affect the patient's ability to perform and maintain recommended medical care. On the one hand, the psychological problems of chronic diseases, including diabetes, which are often overlooked, highlight the need for more attention to appropriate treatment. One of the treatments is Acceptance and Commitment Therapy (ACT). This therapy belongs to the third wave of cognitive–behavioral therapies that enhances one's psychological well–being rather than changing cognitions. Therefore, the present study aimed to determine the effectiveness of ACT on anxiety, depression, and blood lipid profile of patients with type 2 diabetes.
Methods: This study was a quasi–experimental study with a pretest–posttest design and a control group. The study population consisted of all type 2 diabetic patients referred to Birjand Diabetes Clinic in the spring of 2010. A total of 40 patients were selected and randomly assigned into two groups of 20 experimental and control groups. The ACT intervention was performed in eight 90–minute sessions. Data were collected by completing the Anxiety and Depression Scale (Levibond and Lovebond, 1995) and measuring blood lipid indexes before and after the intervention. Ethical considerations included accepting volunteer members in the group counseling sessions, willingly completing the questionnaires by the samples, proper scheduling of meetings, and keeping the information and names of individuals in the study confidential. It is worth noting that this study was approved by the Ethics Committee of Birjand University of Medical Sciences under code Ir.Mums.REC.1398.189. Data analysis was performed by calculating mean and standard deviation in the descriptive part and univariate and multivariate analysis of covariance in the inferential part in SPSS version 22. The significance level was considered at α=0.05.
Results: After the intervention, depression and anxiety scores and lipid indices were significantly decreased in the experimental group compared to the control group (p<0.001). The Eta coefficients for the depression variable (0.220), the anxiety variable (0.0301), total cholesterol (0.257), triglyceride (0.397), LDL–cholesterol (0.184), and HDL–cholesterol (0.171) indicated the efficacy of ACT in reducing anxiety, depression and lipid profile in type 2 diabetic patients.
Conclusion: The results showed that after the intervention, the anxiety, depression, and lipid profile in type 2 diabetic patients were significantly reduced in the experimental group compared to the control group. So, it is recommended that this treatment be used as a complementary treatment for other psychosomatic diseases.

Keywords: Acceptance and commitment therapy, Anxiety, Depression, Lipids, Type 2 diabetes

Full-Text [PDF 725 kb] (282 Downloads)

Type of Study: Original Research Article | Subject: Psychology

References

1. Meusel L-AC, Kansal N, Tchistiakova E, Yuen W, MacIntosh BJ, Greenwood CE, et al. A systematic review of type 2 diabetes mellitus and hypertension in imaging studies of cognitive aging: time to establish new norms. Front Aging Neurosci. 2014;6:148–55. [DOI]

2. DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1(1):15019. [DOI]

3. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010;87(1):4–14. [DOI]

4. Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the global burden of disease study 2013. The Lancet Neurology. 2016;15(9):913–24.

5. Da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, Guariguata L, Seuring T, Zhang P, et al. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Research and Clinical Practice. 2016;117:48–54. [DOI]

6. Ghazi A, Landerman LR, Lien LF, Colon-Emeric CS. Impact of race on the incidence of hypoglycemia in hospitalized older adults with type 2 diabetes. Clinical Diabetes. 2013;31(2):66–72.

7. Arigo D, Smyth JM, Haggerty K, Raggio GA. The social context of the relationship between glycemic control and depressive symptoms in type 2 diabetes. Chronic Illness. 2015;11(1):33–43. [DOI]

8. Davis SL, Kaulfers A-M, Lochman JE, Morrison SA, Pryor ER, Rice M. Depressive symptoms, perceived stress, and cortisol in school-age children with type 1 diabetes: a pilot study. Biological Research for Nursing. 2019;21(2):166–72. [DOI]

9. Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care. 2000;23(10):1556–62. [DOI]

10. Ford DE. Optimizing outcomes for patients with depression and chronic medical illnesses. American Journal of Medicine. 2008;121(11):38–44. [DOI]

11. Ghaedi Heydari F, Toghian Chaharsoghi N. The effect of simultaneous incidence of diabetes and depression. Jorjani Biomed J. 2012;0(1):1–8. [Persian] [Article]

12. Riley AA, McEntee ML, Gerson L, Dennison CR. Depression as a comorbidity to diabetes: implications for management. The Journal for Nurse Practitioners. 2009;5(7):523–35. [DOI]

13. Lee FE, McCarty N. The anxieties of American democracy. In: Lee FE, McCarty N, editors. Can America govern itself? First edition. Cambridge University Press; 2019. pp:1–23. [DOI]

14. Das-Munshi J, Stewart R, Ismail K, Bebbington PE, Jenkins R, Prince MJ. Diabetes, common mental disorders, and disability: findings from the UK national psychiatric morbidity survey. Psychosomatic Medicine. 2007;69(6):543–50. [DOI]

15. Cakir L, Cakir SA, Enginyurt O. Anxiety and depression are binary disrupt diabetic control. Medical Research. 2014;4(4):279–82.

16. Anstey KJ, Von Sanden C, Sargent-Cox K, Luszcz MA. Prevalence and risk factors for depression in a longitudinal, population-based study including individuals in the community and residential care. The American Journal of Geriatric Psychiatry. 2007;15(6):497–505. [DOI]

17. Zare H, Zare M, khalegi Delavar F, Amirabadi F, Shahriari H. Mindfulness and diabetes: evaluation of effectiveness of mindfulness based stress reductionon glycemic control in diabetes. Razi Journal of Medical Sciences. 2013;20(108):40–52. [Persian] [Article]

18. Rahimi N, Marandi SM, Esfarjani F, Ghasemi GH, Habibi N. The effect of one cycle of yoga exercises on blood lipid of the female patients with type II diabetes. Sadra Medical Sciences Journal. 2014;2(3):223–34. [Persian] [Article]

19. Grundy SM, Bilheimer D, Chait A. Summary of the second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). JAMA. 1993;269(23):3015. [DOI]

20. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Cayatte AJ, Rozek MM. Pathogenesis of the atherosclerotic lesion: implications for diabetes mellitus. Diabetes Care. 1992;15(9):1156–67. [DOI]

21. Association AD. Detection and management of lipid disorders in diabetes. Diabetes Care. 1995;18(Suppl 1):86–93. [DOI]

22. Walker AR. Disease patterns in South Africa as related to dietary fiber intake. In: Spiller GA. CRC handbook of dietary fiber in human nutrition. 3rd edition. California: Health Research and Studies Center; 2001. pp:491–5.

23. Denke MA, Sempos CT, Grundy SM. Excess body weight: an under-recognized contributor to dyslipidemia in white American women. Arch Intern Med. 1994;154(4):401–10. [DOI]

24. Hor M, Kanani K, Aghaie A, Abedi A. The effect of acceptance and commitment therapy on the degree of depression in type 2 diabetic patients. Interdisciplinary Journal of Contemporary Research in Business. 2014;6(1):246–5. [Persian]

25. Azemi Zeynal A, Ghaffari A, Sharghi A. The effectiveness of acceptance and commitment therapy based on depression, mental health and physically health in hemodialysis patients. J Fundamentals of Mental Health. 2016;18(Special Issue):412–18. [Persian] [Article]

26. Joshan-Poush S, Fazilat-Pour M, Rahmati A. The effectiveness of parent-child relationship training based on ACT on the parent-adolescent conflict of mothers with epileptic child. Research in Cognitive and Behavioral Sciences. 2017;7(2):39–50. [Persian] [Article]

27. Alavizadeh F, shakerian A. The effectiveness of acceptance and commitment therapy on reducing stress, anxiety and depression in married females experiencing infidelity (emotional- sexual). Journal of Psychiatric Nursing. 2017;4(6):8–14. [Persian] [Article]

28. Mohammadi T, Rah Nejat AM, Esmaeili A, Taghva A, Shahmiri H, Dabaghi P. The impact of acceptance and commitment therapy on reducing of depression and anxiety in patients with type-1 diabetes. EBNESINA. 2018;20(1):48–55. [Persian] [Article]

29. Bastami M, Goodarzi N, dowran B, Taghva A. Effectiveness of treatment acceptance and commitment therapy (ACT) on the reduction of depressive symptoms of military personnel with type 2 diabetes mellitus. EBNESINA. 2016;18(1):11–8. [Persian] [Article]

30. Hor M, Aghaie A, Abedi A, Attari A. The effectiveness of acceptance and commitment therapy on depression in patients with type 2 diabetes. J Research in Behavioural Sciences. 2013;11(2):121–28. [Persian] [Article]

31. Moghanloo VA, Moghanloo RA, Moazezi M. Effectiveness of acceptance and commitment therapy for depression, psychological well-being and feeling of guilt in 7–15 years old diabetic children. Iranian Journal of Pediatrics. 2015;25(4):e2436. [DOI]

32. Fathi Ahmadsaraei N, Neshat Doost HT, Manshaee GR, Nadi MA. The effectiveness of acceptance and commitment therapy on depression among patients with type II diabetes. Iran J Diabetes and Obesity. 2017;9(1):6–13. [Persian] [Article]

33. Zettle RD. Acceptance and commitment therapy for depression. Current Opinion in Psychology. 2015;2:65–9. [DOI]

34. Behrouz B, Bavali F, Heidarizadeh N, Farhadi M. The effectiveness of acceptance and commitment therapy on psychological symptoms, coping styles, and quality of life in patients with type-2 diabetes. Journal of Health. 2016;7(2):236–53. [Persian] [Article]

35. Nazem F, Rahman Nezhad H. Tasire varzeshe havazi zirbishine bar pasokhe libo protein haye plasmaye khoon mardan diabeti IDDM [The effect of sub-maximal aerobic exercise on response of blood plasma lipoproteins in diabetic men IDDM]. Harakat. 2001;9(9):5–30. [Persian] [Article]

36. Xie W, Zhao Y, Zhang Y. Traditional Chinese medicines in treatment of patients with type 2 diabetes mellitus. Evidence-Based Complementary and Alternative Medicine. 2011:726723. [DOI]

37. Delavar A. Educational and psychological research. Tehran: Virayesh; 2015. [Persian]

38. Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the Beck depression and anxiety inventories. Behavior Research nd Therapy. 1995;33(3):335–43. [DOI]

39. Sahebi A, Asghari MJ, Salari RS. Validation of depression anxiety and stress scale (DASS-21) for an Iranian population. J Developemental Psychology. 2005;1(4):36–54. [Persian] [Article]

40. Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: the process and practice of mindful change. Second edition. New York: Guilford Press; 2011.

41. Esmi Z. Asarbakhshiye darman mobtani bar paziresh va ta'ahod (ACT) bar salamat ravan, keyfiyat zendegi va raftarhaye khod moraghebati bimaran mobtala be saratane pestan [Effectiveness of acceptance and commitment therapy (ACT) on mental health, quality of life and self-care behaviors in breast cancer patients] [Thesis for MSc in clinical psychology]. [Tehran, Iran]: Faculty of psychology and educational sciences, Alzahra University; 2016.

42. Kim YH, Kim HJ, Do Ahn S, Seo YJ, Kim SH. Effects of meditation on anxiety, depression, fatigue, and quality of life of women undergoing radiation therapy for breast cancer. Complementary Therapies in Medicine. 2013;21(4):379–87. [DOI]

43. Forman EM, Herbert JD. New directions in cognitive behavior therapy: acceptance-based therapies. In: O'Donohue WT, Fisher JE, editors. General principles and empirically supported techniques of cognitive behavior therapy. Hoboken, NJ: John Wiley & Sons; 2009. pp:77–101.

44. Pourfarahani M, Brabadi HA, Heydarnia A. The effectiveness of acceptance and commitment group therapy on avoiding experiences & physiological signs in social anxiety disorder of orphaned adolescent girls. Analytical-Cognitive Psycholoy. 2019; 9(35):61–72. [Persian]

45. Bach PA, Moran DJ. ACT in practice: case conceptualization in acceptance & commitment therapy. Ockland, CA: New Harbinger Publications; 2008.

46. Rahl HA, Lindsay EK, Pacilio LE, Brown KW, Creswell JD. Brief mindfulness meditation training reduces mind-wandering: the critical role of acceptance. Emotion. 2017;17(2):224–30. [DOI]

47. Lee EB, An W, Levin ME, Twohig MP. An initial meta-analysis of acceptance and commitment therapy for treating substance use disorders. Drug and Alcohol Dependence. 2015;155:1–7. [DOI]

48. Harris R. ACT made simple: an easy-to-read primer on acceptance and commitment therapy. Oakland: New Harbinger Pub; 2019.